Date of Document: March 24, 2023
CURRICULUM VITAE

Ahmed Zayed Obeidat MD, PhD
Associate Professor
Department of Neurology
Division of General

OFFICE ADDRESS:
Hub for Collaborative Medicine
8701 Watertown Plank Road
Milwaukee, WI 53226
Fax: 4149550127

EDUCATION:
10/01/2002 - 06/30/2008 MBBS, Jordan University of Science and Technology, Irbid, Jordan
09/01/2009 - 05/30/2013 Ph.D. (Doctor of Philosophy), Wright State University, Dayton, OH
05/25/2015 - 05/27/2015 Non-degree - program name: Master of Multiple Sclerosis
07/01/2019 - 06/03/2020 Certificate of Medical Education-Educational Transformation in Teaching, Kern Institute, Medical College of Wisconsin, Milwaukee, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/01/2008 - 07/15/2009 Intern physician, Internal Medicine, Surgery, Pediatrics, Ministry of Health Hospitals, Irbid - Jordan
07/01/2013 - 06/30/2014 Medical Internship, Internal Medicine, University of Cincinnati, Cincinnati, OH
07/01/2014 - 06/30/2017 Resident Physician, Neurology, University of Cincinnati, Cincinnati, OH
07/01/2017 - 06/30/2018 Fellow Physician, Neurology, Neuroimmunology and Multiple Sclerosis, University of Cincinnati, Cincinnati, OH

FACULTY APPOINTMENTS:
07/01/2018 - Present Assistant Professor, Neurology, Neuroimmunology and Multiple Sclerosis, Medical College of Wisconsin, Milwaukee, WI 53226

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
09/01/2018 - Present Founding Director, Neuroimmunology & MS Fellowship Program, Neurology, Medical College of Wisconsin

HOSPITAL STAFF PRIVILEGES:
07/16/2018 - Present Staff Physician, Neurology, Froedtert and the Medical College of Wisconsin
10/01/2020 - Present Staff Physician, Neurology, Children's Hospital of Wisconsin

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Psychiatry and Neurology ABPN
09/11/2017
09/10/2027
   
Licensure
Number Issue DateExpiration
Medicine and Surgery
69028
03/22/2018
10/31/2021
    

AWARDS AND HONORS:
08/2002 National (Tawjihi) Certification Exam (National High School Cumulative Exam): Score of 96.4%, among the top 100 scores in the nation, National Jordanian High School Exam
09/2002 - 06/2008 Faculty of Medicine honor list, Top 5% of class, Jordan University of Science and Technology
2002 - 2003 President’s honor list, Jordan University of Science and Technology
01/2008 - 03/2008 Travel Award to the University of Texas Medical Branch, Galveston, TX in support of two months elective training in Clinical Neurology, International Brain Research Organization (IBRO)
06/2008 Ranked 4th among 315 medical school graduates , Jordan University of Science and technology
01/2010 - Present Travel Award to Mahidol University, Bangkok-Thailand for attending the 14th IBRO‐APRC Associate School of Neuroscience “Synaptic Plasticity: From Basics to Clinical applications, International Brain Research Organization (IBRO)
06/01/2010 - Present Phi Kappa Phi Inductee, The Phi Kappa Phi Honor Society
2010 The most engaging country display “JORDAN,” during the 26th Annual Friendship Affair, Wright State University
05/18/2011 Graduate Student Excellence Award , Wright State University
06/01/2011 - Present Nominated member to the American Association for the Advancement of Science / Program for Excellence in Science , AAAS
08/30/2011 First Place Superior Platform Presentation , Wright State University
04/2012 Graduate Student Assembly Professional Development Award in support of attending the American Physician Scientist Association 8th Annual Meeting, Wright State University
05/01/2012 - 06/30/2013 President's Ambassador, Wright State University
05/2012 Best Poster Award , Ohio Miami Valley Society for Neuroscience
08/2012 Internal Pilot Grant - Recurrent Inhibition , Wright State University
2012 American Physician Scientist Association Travel Award, American Physician Scientist Association
11/2014 Above and Beyond Resident Award, University of Cincinnati
12/2014 Above and Beyond Resident Award, University of Cincinnati
05/2015 cholarship to attend the Consortium of Multiple Sclerosis Centers Annual Meeting, The Consortium of MS Centers
05/2015 Resident Scholar Award , The Foundation of the Consortium of Multiple Sclerosis Centers
06/2015 Scholarship to attend the Clinical Neuroscience Expo, University of Kentucky
08/2015 Scholarship to attend Gordon Research Conference: Inhibition in the CNS
12/2015 Above and Beyond Resident Award, University of Cincinnati
2015 PCORI travel award to attend PCORI annual meeting, The Patient-Centered Outcomes Research Institute
02/2016 The International Junior Stroke Investigator Award , International Stroke Organization
10/2016 "Best in Class" Multiple Sclerosis Challenging Cases, PRIME's GME Today Advance Practice in Multiple Sclerosis
2016 - 2018 Educational Grant Travel Award - 3 consecutive years, ACTRIMS
2016 PCORI travel award to attend the “Getting to Know PCORI, The Patient-Centered Outcomes Research Institute
01/2017 Above and Beyond Resident Award, University of Cincinnati
04/2017 Resident Scholarship to the Annual Meeting, The American Academy of Neurology
07/01/2017 - 06/30/2018 NMSS Clinical Care Fellowship, National Multiple Sclerosis Society
09/01/2017 - Present Alpha Omega Alpha Inductee , Alpha Omega Alpha Honor Medical Society
2017 - 2018 Clinical Care Fellowship, National MS Society
04/2018 Fellow Scholarship to the Annual Meeting, The American Academy of Neurology
10/10/2018 Certificate of Appreciation in recognition of superior performance , Neuroscience Clinic Management
2018 Fellow Award and Annual Meeting Scholarship, American Academy of Neurology
2019 Top Patient Experience Award, Froedtert and the Medical College of Wisconsin
2019 - 2020 Outstanding Medical Student Teaching Award, Medical College of Wisconsin
2020 Faculty Global Health Travel Scholarship, Medical College of Wisconsin
2020 Imagine More Award, Neuroscience Research Center
06/13/2021 Most Impactful Team Award, Tech Serum - Microsoft Healthcare's Hackathon

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2005 - 2009 Jordanian Cystic Fibrosis Society
2006 - 2009 Jordanian Multiple Sclerosis Society
2007 - Present Society for Arab Neuroscientists
2007 - 2009 Jordanian Family and Child Protection Society
2007 - Present International Brain Research Organization (IBRO)
2010 - Present American Physician Scientist Association
2010 - Present The Phi Kappa Phi Honor Society
2010 - Present Society for Neuroscience
2011 - Present The American Association for the Advancement of Science/ Program for Excellence in Science
2013 - Present American Academy of Neurology
2015 - Present Foundation of the Consortium of Multiple Sclerosis Centers
2015 - Present The Consortium of Multiple Sclerosis Centers
2015 - 2016 The American Heart Association
09/2017 - Present Alpha Omega Alpha Honor Medical Society
2017 - Present Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
2021 - Present GENERATIONS - a publication by the Consortium of MS Centers and the Foundation of the CMSC
Editorial Board
01/01/2019 - 01/01/2022 International Journal of MS Care
04/01/2021 - Present Multiple Sclerosis and Neuroimmunology (specialty section of Frontiers in Immunology and Frontiers in Neurology)
Journal Review
Journal of Pediatric Neurology
Neurology
Multiple Sclerosis Journal
Journal of Child Neurology
Avicenna Journal of Medicine
Journal of Translational Medicine
Journal of Neurological Sciences
Journal of Pediatric Neurology
Multiple Sclerosis and Related Disorders
Multiple Sclerosis Journal – Experimental, Translational and Clinical
Reviews in the Neurosciences
The Permanente Journal

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2005 - 2009 Member, Executive Committee, Jordanian Cystic Fibrosis Society
2012 Chair, Research Symposium Organizing Committee, Graduate Student Assembly, Wright State University
2015 - 2016 Member, Resident Advisory Council, University of Cincinnati
2018 - Present Member, Neurology Resident Selection Committee, Medical College of Wisconsin
2019 - Present Scientific Review Member, Institutional Review Board (IRB) - Committee #4, Medical College of Wisconsin
2021 - Present Member, MSTP Director search committee, Medical College of Wisconsin

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2014 - Present Communication Officer, Executive Committee, Society for Arab Neuroscientists
2016 - 2019 Co-Chair, MS Professionals-in- Training Special Interest Group (MS-PiT), The Consortium of MS Centers
2016 - Present Member, Board of Governors, The Consortium of MS Centers
2016 Co-Chair, President Search Committee, Society for Arab Neuroscientists
2017 - 2018 Member, Ohio Delegation, American Academy of Neurology - Neurology on the Hill
2018 - 2024 Director of Research, Board of Directors, Global Music and Wellness
2019 - 2022 Member, Advisory Committee, Americas Committee for the Treatment and Research in Multiple Sclerosis (ACTRIMS)
2019 - Present Member, Education Subcommittee, American Academy of Neurology MS Section
2019 - Present Chair, MS Professionals-in- Training Special Interest Group (MS-PiT), Consortium of MS Centers
2019 - Present Member, Mentorship Forum Organizing Committee, Foundation of the Consortium of MS Centers
2020 - Present Member, National Didactic Planning Committee, ACTRIMS
2020 - 2021 Scientific Review Member, Scientific Abstract review, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
2020 - 2021 Scientific Panelist, Peer review panel of the 2020 Multiple Sclerosis Research Program (MSRP), Department of Defense Congressionally Directed Medical Research Programs (CDMRP)
2020 - 2021 Scientific Reviewer, Research Grant Review Committee, The Foundation of the Consortium of MS Centers
2020 - Present Member, Neuroimmunology and MS Fellowship National Curriculum Development and Subspecialty Certification Committee, Multiple Organizations
05/2021 - Present Expert Faculty Member, Best practices in the Use of Disease-Modifying Therapies in MS, The Consortium of MS Centers
2021 Scientific Review Member, Scientific Abstract review, The Consortium of MS Centers
2021 Scientific Review Member, Scientific Abstract review, American Academy of Neurology

INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
01/2007 - 01/2008 Secretary, United Arab Emirates neuroscience school, International Brain Research Organization (IBRO)
2008 - 2009 Member, Abstract Review, International Online Medical Student Conference

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Using art to increase health literacy of physical activity in patients with Parkinson Disease
Source:
Parkinson Foundation, FY19 Community Grants
Role:
Co-Investigator
PI:
Ryan Brennan
Dates:
06/01/2020 - 12/31/2021
  
Title:
Dynamics of B Cell subtypes in multiple sclerosis before and after treatment
Source:
Neurosciences Research Center, Imagine More Grant
Role:
Principal Investigator
Dates:
08/01/2020 - 07/31/2021
Direct Funds:
$25,000
  
Title:
Ethnic and Racial Variation in clinical features and access to clinical care in people living with Multiple Sclerosis
Source:
Foundation of the Consortium of MS Centers
Role:
PI - Mentor
Dates:
06/01/2021 - 07/01/2022
Direct Funds:
$5,000
  
Title:
Tremor Characterization in MS
Source:
Foundation of the Consortium of MS Centers
Role:
PI -Mentor
Dates:
06/01/2021 - 07/01/2022
Direct Funds:
$5,000
  
Title:
Early versus Late Onset Multiple Sclerosis
Source:
Foundation of the Consortium of MS Centers
Role:
PI -Mentor
Dates:
06/01/2021 - 07/01/2022
Direct Funds:
$5,000
  
Non-Peer Review
Title:
Exploring the safety and tolerability of conversion from oral and injectable disease modifying therapies to dose-titrated Oral Siponimod in patients with advancing forms of relapsing multiple sclerosis: A 6-month open label, multi-center Phase IIIb study (EXCHANGE)
Source:
Novartis
Role:
PI
Dates:
05/21/2019 - Present
  
Title:
TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) Trial
Source:
Patient-Centered Outcomes Research Institute (PCORI)
Role:
PI
Dates:
02/02/2020 - 02/01/2024
  
Title:
A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)
Source:
Celgene Corporation
Role:
PI
Dates:
02/10/2020 - 02/09/2023
  
Title:
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Ocrelizumab in Adult Patients with Primary Progressive Multiple Sclerosis
Source:
Genentech Inc
Role:
PI
Dates:
06/01/2020 - 05/31/2024
  
Title:
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With Teriflunomide, in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety.
Source:
EMD Serono Research & Development Institute, Inc.
Role:
PI
Dates:
06/12/2020 - 09/18/2023
  
Title:
An Open-Label, Multicenter Study to Assess Disease Activity and Biomarkers of Neuronal Damage in Minority Patients with Relapsing Multiple Sclerosis Receiving Treatment with Ocrelizumab
Source:
Genentech Inc
Role:
PI
Dates:
06/30/2020 - 06/29/2024
  
Title:
Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis (EMBOLD)
Source:
Atara Biotherapeutics, Inc
Role:
PI
Dates:
01/01/2021 - 12/31/2023
  
Title:
A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH TERIFLUNOMIDE INADULT PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
Source:
Genentech Inc
Role:
PI
Dates:
01/04/2021 - 01/03/2026
  
Title:
FloodlightTM MS Software
Source:
Genentech Inc
Role:
PI
Dates:
06/29/2021 - 06/28/2022
  
Pending
Peer Review
Title:
The role of visual motion mechanisms on balance control in people with Multiple Sclerosis
Source:
NIH Neurological Disorders and Stroke
Role:
Co-I
PI:
Scott Beardsley - Marquette University
  
Title:
Dynamic balance training for recovery of gait function in people with multiple sclerosis
Source:
NIH Child Health and Human Development
Role:
Co-I
PI:
Brian Schmidt - Marquette University
  
Non-Peer Review
Title:
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Arm, Parallel-Group Study in Pediatric Subjects Aged 10 Through 17 Years to Evaluate - BG00012 and BIIB017 for RRMS
Source:
Biogen Inc
Role:
PI
  
Title:
Proof-of-concept Study for SAR441344 in Relapsing Multiple Sclerosis - ACT16877
Source:
Sanofi US
Role:
PI
  
Prior
Peer Review
Title:
The Effect of Ocrelizumab on Lymphocytes in Multiple Sclerosis Previously Exposed to Lymphocyte Depleting Agents
Source:
Foundation of the Consortium of MS Centers
Role:
Co-PI - Mentor
PI:
Aram Zabeti
Dates:
05/01/2018 - 04/30/2019
Direct Funds:
$5,000
  
Title:
Older Adult Bhutanese Refugees: The Impact of Recreational Music Making and Visual Art on Health
Source:
Center for Clinical and Translational Science and Training, Community Health Grants Program, Cincinnati, OH
Role:
Co-I
PI:
Judy Singelton
Dates:
08/01/2018 - 07/31/2019
  
Title:
Regulatory T cell and B cell-subset changes in patients with multiple sclerosis before and after humanized anti-CD20 monoclonal antibody therapy
Source:
Center for Immunology
Role:
PI
Dates:
01/01/2019 - 12/31/2019
Direct Funds:
$30,000
  
Title:
Integration of Technology-Based Objective Measures with Self-Reported Functional Disability: Development of a Patient-Centered Measure of Outcome of Multiple Sclerosis
Source:
Research affairs Committee (RAC)
Role:
PI
Dates:
01/01/2020 - 06/31/2021
Direct Funds:
$25,000
  
Title:
Changes in Immunoglobulins and Lymphocytes in the Peripheral Blood of Patients Receiving B-cell-depleting Therapies for Multiple Sclerosis and Related Disorders
Source:
Foundation of the Consortium of MS Centers
Role:
PI -Mentor
Dates:
06/01/2020 - 05/31/2021
Direct Funds:
$5,000
  
Non-Peer Review
Title:
AFFINITY: Phase 2 clinical trial, designed to evaluate opicinumab as an investigational add-on therapy in people with relapsing multiple sclerosis or MS
Role:
Sub-Investigator
  
Title:
CHORDS: A Study of Ocrelizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) in Multiple Sclerosis (both relapsing remitting and progressive)
Role:
Sub-Investigator
  
Title:
Safety and Efficacy Study of Elezanumab in Relapsing and progressive Forms of Multiple Sclerosis
Source:
Abbvie
Role:
Sub-Investigator
PI:
Staley Brod
  
Title:
ASSESS: A 12 months randomized, rater and dose blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg given subcutaneously once daily in patients with relapsing remitting Multiple Sclerosis
Role:
Sub-Investigator
  
Title:
OPTIONS: pilot study to assess the efficacy & safety of h.p. acthar gel in subjects with relapsing-remitting multiple sclerosis
Role:
Sub-Investigator
  
Title:
SPRINT-MS: Randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and activity of Ibudilast (MN-166) in subjects with progressive Multiple Sclerosis
Role:
Sub-Investigator
  
Title:
OPERA: Randomized, double-blind, parallel-group study to evaluate the efficacy and safety of Ocrelizumab in comparison to Interferon Beta-1a (Rebif) in patients with relapsing Multiple Sclerosis
Role:
Sub-Investigator
  
Title:
Chugai NMO: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to evaluate the Efficacy and safety of SA237 as Monotherapy in Patients with Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
Role:
Sub-Investigator
  
Title:
OPEXA, Abili-T: Phase 2 double-blind, placebo controlled multi-center study to evaluate the efficacy and safety of Tcelna in subjects with secondary progressive Multiple Sclerosis
Role:
Sub-Investigator
  
Title:
Expand: To assess the safety and efficacy of Siponimod (BAF 312) versus placebo in a variable treatment duration in patients with secondary progressive Multiple Sclerosis
Role:
Sub-Investigator
  
Title:
ACTELION: Randomized, double-blind, parallel-group extension to study AC-058B201 to investigate the long-term safety, tolerability, and efficacy of 10, 20, and 40 mg/day ponesimod, an oral S1P1 receptor agonist, in patients with relapsing-remitting multiple sclerosis
Role:
Sub-investigator
  
Title:
MS200527-0086: A Study of Efficacy and Safety of M2951 in Subjects With Relapsing Multiple Sclerosis
Role:
Sub-Investigator
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Ahmed Obeidat, Neural tube defects in the north of Jordan: Is there a seasonal variation?, The Second Conference for Faculty of Medicine at the University of Jordan and 5th Conference for Jordanian Medical Faculties, Amman, Jordan, 05/2009
Ahmed Obeidat, Using in Vivo Physiology to Probe the Beauty of a Spinal Circuit, Biomedical Sciences Ph.D. Research Retreat, Wright State University, 08/2011
Ahmed Obeidat, The Diverse Capacities of CNS Inhibition, The Neuroscience Seminar Series, University of Cincinnati, 03/2015
Ahmed Obeidat, Advances in the Understanding and Treatment of Multiple Sclerosis, Annual Advances in Neurology, Medical College of Wisconsin, 06/14/2019
Ahmed Obeidat, Hearing hoofbeats; Think Zorse!, Neurology Grand Rounds, Medical College of Wisconsin, 04/17/2020
Ahmed Obeidat, B Cells As a Therapeutic Target in Multiple Sclerosis: Past, Present and Future, Neurology Grand Rounds, Medical College of Wisconsin, 10/14/2020
Ahmed Obeidat, Autoimmune CNS disease and neuro manifestations of rheum disease, Rheumatology Conference, Medical College of Wisconsin, 02/24/2021
Ahmed Obeidat, Sam Hooshmand, Multiple Sclerosis and its Mimickers: A Case Based Approach, Headache Medicine & General Neurology Virtual CME Symposium, Medical College of Wisconsin, 03/13/2021
Ahmed Obeidat, Fading memories, vanishing reminiscence and refractory seizures: To name just a few in the world of Autoimmune Encephalitis, Neuropsychology Seminar, Medical College of Wisconsin, 05/11/2021
 
Regional
Ahmed Obeidat, Multiple Sclerosis: Is it the Price Paid for Untreated Emotional Seizure(s) in Susceptible Individuals?, University of Toledo Midwest Graduate Research Symposium, Toledo, OH, 03/2011
Ahmed Obeidat, Recurrent Inhibition and Peripheral Nerve Injury, University of Toledo Midwest Graduate Research Symposium, Toledo, OH, 03/2012
Ahmed Obeidat, Technology in MS care – An opportunity to make an impact, Biomedical Engineering Seminar series., Marquette University. Milwaukee, WI, 12/06/2019 - Present
 
National
Ahmed Obeidat, Navigating Your Career: Training in Neurology While on a Visa: Challenges and Possible Solutions for Foreign Medical Graduates, American Academy of Neurology Annual Meeting in 2017 and in 2018 (invited again due to the lecture impact), Boston, MA and Los Angeles, CA, 2017 - 2018
Ahmed Obeidat, Navigating Your Career: Navigating Fellowship in Neurology, American Academy of Neurology Annual Meeting 2017 and 2018 - Invited again in 2018 due to the lecture impact, Boston, MA and Los Angeles, CA, 2017 - 2018
Ahmed Obeidat, Medical Humanities, reflective writing, and visual arts in multiple sclerosis, CMSC Annual Meeting, Seattle Washington, 2019
Ahmed Obeidat, Selected Hot Topics in MS, Grand Rounds, Novartis headquarters, East Hanover, NJ, 03/12/2020
Ahmed Obeidat, B cells as a therapeutic target in Multiple Sclerosis: Past, Present and Future, Grand Rounds, George Washington Neurology Department, 11/03/2020
Ahmed Obeidat, A group leader for a Gather-Ed CME experience entitled: “Following the Trail of Evidence to Individualize and Optimize Multiple Sclerosis Care”, Online, https://spire.gathered.com/group/208/dashboard, 02/02/2021 - 07/15/2021
 
International
Ahmed Obeidat, Highlights of My Experience While Communicating with Elderly in Dementia Research, First Arab Neuroscience School, Faculty of Medicine, United Arab Emirates University, Al Ain, UAE, 11/2007
Ahmed Obeidat, Multiple Sclerosis in Jordan: Epidemiology and Achievements, Department of Neurology weekly seminar, University of Texas Medical Branch at Galveston, TX, 02/2008
Ahmed Obeidat, atest scientific developments in the diagnosis and treatment of multiple sclerosis (MS) and neuro-immunological diseases, Hospital-Wide Grand Rounds, Jordan University of Science and Technology and King Abdullah University Hospital, 07/01/2019
Ahmed Obeidat, Professor Clinical Rounds, King Abdullah University Hospital, Irbid, Jordan, 07/14/2019 - 07/15/2019
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
03/2019 - Present Myelination disorders - M2 – Basic Science Courses - Yearly teaching
03/02/2021 Art of Medicine through the Humanities class - Islam and the Medical Ethics: Past and Present Caring for the Muslim patient
 
Resident and Fellow Education
08/31/2018 Academic Half Day: management of Neuromyelitis Optica in the hospital setting
11/30/2018 Academic Half Day: Pathophysiology, Diagnosis and Variants of MS
11/30/2018 Academic Half Day: MS Treatment
02/22/2019 Joint Academic Half Day with ophthalmology
11/13/2020 Academic Half Day: MS and related disorders
12/04/2020 Academic Half day: MS and related disorders
12/11/2020 Academic Half Day: MS and related disorders
 

EXTRAMURAL TEACHING:
Community/Lay Public
11/01/2018 Froedtert/MCW, Multiple Sclerosis and Stress
03/27/2019 Froedtert/MCW, Technology Integration in Multiple Sclerosis Care
11/12/2020 Froedtert/MCW, Multiple Sclerosis: What's New?
 
Resident and Fellow Education
03/06/2019 Community Memorial Hospital Family Medicine Residency, Multiple sclerosis for family medicine
11/11/2020 Community Memorial Hospital Family Medicine Residency, Neuroimmunology, MS and GBS in primary care
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Mokshal Porwal, Medical College of Wisconsin, 01/01/2020 - Present Research and Academic mentor, Project: Safety of Disease Modifying therapies in Multiple Sclerosis. Two manuscripts under peer review. Two accepted abstracts, and two manuscripts in final preparation.
Calin Dumitrescu, Medical College of Wisconsin, 03/01/2020 - Present Clinical research and academic mentor, Project: Changes in Immunoglobulins and Lymphocytes in the Peripheral Blood of Patients Receiving B-cell- depleting Therapies for Multiple Sclerosis and Related Disorders. (one poster presentation; one poster to be presented in October 2021; Medical student research grant from the Foundation of the Consortium of MS Centers).
Britta Bureau, Medical College of Wisconsin, 06/01/2020 - Present Research and Academic mentor, One published manuscript, one conference abstract, and applying for neurology residency.
Murali Palathinkara, Medical College of Wisconsin, 04/01/2021 - Present Research and academic mentorship, Project: Early versus Late Onset Multiple Sclerosis. Awarded the Foundation of the Consortium of MS Centers Research Grant
Delaney Cairns, Medical College of Wisconsin, 04/01/2021 - Present Research and academic mentorship, roject: Ethnic and Racial Variation in clinical features and access to clinical care in people living with Multiple Sclerosis. Awarded the Foundation of the Consortium of MS Centers research grant, and awarded the Wisconsin Medical Society Foundation Summer Fellowship.
Camila Ishueva, Medical College of Wisconsin, 04/01/2021 - Present Research and academic mentorship, Project: Analysis of tremor in multiple sclerosis. Awarded the Foundation of the Consortium of MS Centers research grant. One manuscript in final stages of preparation
Casey Vickstrom, Medical College of Wisconsin, Academic Advisor
 
Clinical/Research Fellows
Nicola Carlisle, Medical College of Wisconsin, 07/01/2019 - 06/30/2020 Program director, research and academic mentor, Completed fellowship in MS and Neuroimmunology. Joined an established neurology group a an MS specialist. published several manuscripts and abstracts.
Sam Hooshmand, Medical College of Wisconsin, 07/01/2020 - 06/30/2021 Program director, research and academic mentor, Completed fellowship in MS and Neuroimmunology, started faculty appointment at MCW. published several manuscripts and abstracts and obtained several research and academic awards
 
Residents
Allison Block, DO, Medical College of Wisconsin, 01/01/2019 - Present Research and academic advisor, Project: Anti MOG associated disease. 2 published manuscript, 1 manuscript under peer review, 1 manuscript in final preparation, 3 published abstracts, and one top scoring abstract for ACTRIMS 2021. Also successfully obtained a fellowship position at the University of Chicago
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Medical Students
Samuel Marcucci, University of Cincinnati, 07/01/2017 - Present Research and Academic Mentor, Research grant, one published manuscript, two published abstracts, successful matching into neurology residency
Mohammad Adawi, MD, University of Nebraska Medical Center, 10/01/2018 - Present Research and Academic, Successfully matched in neurology residency at the University of Nebraska. Also, one published abstract and one manuscript in preparation. Project: Anti Ma2 Limbic Encephalitis.
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Fellow
07/01/2019 - Present Founded the first fellowship program in Neuroimmunology and Multiple Sclerosis in the state of Wisconsin.
 
 
 
 

GLOBAL HEALTH ACTIVITIES:
07/01/2019 - Present Established a collaboration with researchers at the Jordan University of Science and Technology. We have published one manuscript, and have two abstracts accepted for poster presentations.
 

MEDIA APPEARANCE:
Article on Wright State University website about my research. http://webapp2.wright.edu/web1/dialogue/2012/10/spinal-cord-circuit-that-controls-body- movement-focus-of-wright-state-neuroscience-research/
Podcast on Music and Wellness WMKV local music radio channel https://ice7.securenetsystems.net/media/WMKVFM/ondemand/Healthscope%20for%20April%2016th%202018.m4a
Where Art Meets Science: CMSC Speakers Show How Artistic Expression Can Be Part of MS Management. http://delmedgroup.com/Daily_2019/May30/artistic-expression.html
https://www.tmj4.com/news/local-news/multiple-sclerosis-now-impacting-approx-1-million-americans

NEUROLOGY LIVE: THE EVERY CHANGING FACE OF MULTIPLE SCLEROSIS:
This is a series of Webinars that I create, design, prepare and present. In each episode, I invite two experts in the field to discuss a topic related to MS. the events are free to attend and are highly attended by international audience. https://www.neurologylive.com/authors/ahmed-obeidat-md-phd


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Obeidat AZ, Amarin Z. Neural tube defects in the north of Jordan: is there a seasonal variation? J Child Neurol. 2010 Jul;25(7):864-6.
2. Amarin ZO, Obeidat AZ. Effect of folic acid fortification on the incidence of neural tube defects. Paediatr Perinat Epidemiol. 2010 Jul 01;24(4):349-51.
3. Obeidat AZ, Nardelli P, Powers RK, Cope TC. Modulation of motoneuron firing by recurrent inhibition in the adult rat in vivo. J Neurophysiol. 2014 Nov 01;112(9):2302-15. PMCID: PMC4274916
4. Obeidat AZ, Jacob C, Zabeti A. Concurrent Dawson's Fingers and Area Postrema Lesion in a Mixed Neuroimmune Disorder. Can J Neurol Sci. 2017 Jul;44(4):452-454.
5. Obeidat AZ, Broderick JP. Teaching Neuro<i>Images</i>: Crying thalamus: Manifestation of acute ischemic stroke. Neurology. 2017 Feb 28;88(9):e72-e73. PMCID: PMC5331865
6. Obeidat AZ. Cocaine as a potential trigger for Neuromyelitis Optica. J Neurol Sci. 2018 Jul 15;390:99-101.
7. Van Sanford C, Obeidat AZ, Hagen M, Zabeti A. A case of fatal invasive aspergillosis in a patient with neurosarcoidosis treated with infliximab. Int J Neurosci. 2019 Jun;129(6):619-622.
8. Marcucci SB, Obeidat AZ. EBNA1, EBNA2, and EBNA3 link Epstein-Barr virus and hypovitaminosis D in multiple sclerosis pathogenesis. J Neuroimmunol. 2020 Feb 15;339:577116.
9. Kwon SY, Obeidat AZ, Sekar P, Moomaw CJ, Osborne J, Testai FD, Koch S, Lowe MR, Demel S, Coleman ER, Flaherty M, Woo D. Risk factors for seizures after intracerebral hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study. Clin Neurol Neurosurg. 2020 May;192:105731. PMCID: PMC7183434
10. Obeidat AZ, Jassam YN, Hua LH, Cutter G, Ford CC, Halper J, Lisak RP, Sicotte NL, Longbrake EE. Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States. Neurology. 2020 Mar 17;94(11):495-500. PMCID: PMC9246053
11. Block A, Champeau D, Carlson C, Helms A, Obeidat AZ. Anti-myelin oligodendrocyte glycoprotein (MOG) associated disease masquerading as prolonged intractable nausea and vomiting. Mult Scler Relat Disord. 2020 Sep;44:102308.
12. Hua LH, Obeidat AZ, Longbrake EE. Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees. Mult Scler Relat Disord. 2020 Sep;44:102296. PMCID: PMC8023409
13. Hooshmand SI, Chow K, Obeidat AZ. Teaching NeuroImages: Cytotoxic Lesion of the Corpus Callosum Secondary to Influenza A. Neurology. 2021 Mar 23;96(12):e1697-e1698.
14. Bureau BL, Obeidat A, Dhariwal MS, Jha P. Peripheral Neuropathy as a Complication of SARS-Cov-2. Cureus. 2020 Nov 12;12(11):e11452. PMCID: PMC7673277
15. Naismith RT, Bermel RA, Coffey CS, Goodman AD, Fedler J, Kearney M, Klawiter EC, Nakamura K, Narayanan S, Goebel C, Yankey J, Klingner E, Fox RJ, SPRINT-MS investigators. Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study. Neurology. 2021 Jan 26;96(4):e491-e500. PMCID: PMC7905793
16. El-Salem K, Khalil H, Al-Sharman A, Al-Mistarehi AH, Yassin A, Alhayk KA, Qawasmeh MA, Bashayreh SY, Kofahi RM, Obeidat AZ. Serum vitamin d inversely correlates with depression scores in people with multiple sclerosis. Mult Scler Relat Disord. 2021 Feb;48:102732.
17. Cotchett KR, Dittel BN, Obeidat AZ. Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis. Mult Scler Relat Disord. 2021 Apr;49:102787. PMCID: PMC9246073
18. Obeidat AZ, Block AN, Hooshmand SI. "Peppering the pons": CLIPPERS or myelin oligodendrocyte glycoprotein associated disease? Mult Scler Relat Disord. 2021 Jun;51:102874.
19. Nothem ME, Lee RM, Katz JM, Bergl PA, Obeidat AZ. Clinical Reasoning: A 42-Year-Old Woman With Mysterious Monocytic Meningitis. Neurology. 2021 Aug 31;97(9):449-454.
20. Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S. Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Neurology: Clinical Practice. 2021 Jan 18.
21. Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S, Newsome SD, Shah S, Sicotte NL, Yadav V, Longbrake EE. Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Neurol Clin Pract. 2021 Aug;11(4):352-357. PMCID: PMC8382436
22. Porwal MH, Patel D, Maynard M, Obeidat AZ. Disproportional increase in psoriasis reports in association with B cell depleting therapies in patients with multiple sclerosis. Mult Scler Relat Disord. 2022 Jul;63:103832.
23. Burtchell J, Clemmons D, Clemmons J, Sabutis T, Rosenberg A, Graves J, Sweeney ML, Kramer J, Ziehn M, Brown B, Weiss JL, Obeidat AZ. A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies. Neurol Ther. 2022 Sep;11(3):955-979. PMCID: PMC9127487
24. Porwal MH, Salter A, Patel D, Obeidat AZ. Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies. J Cent Nerv Syst Dis. 2022;14:11795735221109674. PMCID: PMC9234852
25. Riem L, Beardsley SA, Obeidat AZ, Schmit BD. Visual oscillation effects on dynamic balance control in people with multiple sclerosis. J Neuroeng Rehabil. 2022 Aug 17;19(1):90. PMCID: PMC9382748
26. Porwal MH, Obeidat AZ. Author response to comment on: Alopecia in multiple sclerosis patients treated with disease modifying therapies. J Cent Nerv Syst Dis. 2022;14:11795735221127131. PMCID: PMC9527983
27. Drom C, Schenheit K, Matzke M, Obeidat AZ, Molinaro J, Charlson J, Knight JM. Abrupt onset of severe parkinsonism in a patient with metastatic gastrointestinal stromal tumor receiving treatment with avapritinib: A case report. Brain Behav Immun Health. 2023 Feb;27:100570. PMCID: PMC9791578
28. Titcomb TJ, Bostick M, Obeidat AZ. Opinion: The role of the registered dietitian nutritionist in multiple sclerosis care in the United States. Front Neurol. 2023;14:1068358. PMCID: PMC9947712
 
Books, Chapters, and Reviews
1. Chirra M, Marsili L, Wattley L, Sokol LL, Keeling E, Maule S, Sobrero G, Artusi CA, Romagnolo A, Zibetti M, Lopiano L, Espay AJ, Obeidat AZ, Merola A. Telemedicine in Neurological Disorders: Opportunities and Challenges. Telemed J E Health. 2019 Jul;25(7):541-550. PMCID: PMC6664824
 
Editorials, Letters to Editor, Other
1. Obeidat AZ. John F. Kurtzke, MD (1926-2015). Neuroepidemiology. 2016;46(2):118-9.
2. Obeidat A. Disconnection. Perm J. 2016;20(3):15-165. PMCID: PMC4991925
3. Obeidat AZ. Her Glistening Eyes. Perm J. 2016;20(4):15-227. PMCID: PMC5101105
4. Ahmed Z. Obeidat. Fragile Scream Neurology. Neurology Feb 2018, 90 (9) 427; DOI: 10.1212/WNL.0000000000005015.
5. Al-Khun N, Obeidat AZ. The unseen but felt. Neurology. 2018 Feb 27;90(9):428.
6. Obeidat AZ, Al-Khun N. Balloons of Hope. Perm J. 2018;22:18-024. PMCID: PMC6047848
7. Obeidat AZ. Time Is Brain and Spine. JAMA Neurol. 2019 May 01;76(5):623.
8. Obeidat AZ, El-Salem K. A national telemedicine program in the Kingdom of Jordan - Editorial. Ann Med Surg (Lond). 2021 Feb;62:145-149. PMCID: PMC7820302
9. Obeidat AZ. Reader response: Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.
10. Obeidat, AZ. E-Pearl on Neurology Podcast: Immunotherapy responsive seizures, posted online at www.neurology.org on 11/23/2015
 
Abstracts
1. Hooshmand S, Obeidat A, Brod S. Reactivation of Latent Neuromyelitis Optic Secondary to COVID-19 Infection: A Case Report (4562).
2. Hooshmand S, Brod S, Obeidat A. Transverse Myelitis as a Presenting Sign of Intravascular Lymphoma: A Report of Two Cases (2902).
3. Block A, Bureau BL, Cotter A, Kamalia M, Jha P, Obeidat A. Intravenous Immunoglobulin Use in West Nile Encephalitis: A report of two cases.(5081).
4. Block AN, Obeidat AZ. (CRS01) Seasonal Variation and Other Observations in Myelin Oligodendrocyte Glycoprotein (MOG) Antibody--Associated Disease. International Journal of MS Care. 2020 May 2;22.
5. Carlisle N, Hooshmand SI, Maynard M, Obeidat AZ. (CRS11) Remarkable Recovery of Fulminant Multiple Sclerosis After Treatment Induction with Cyclophosphamide. International Journal of MS Care. 2020 May 2;22.
6. Carlisle N, Hooshmand SI, Maynard M, Hoffman L, Obeidat AZ. (DXT55) Herpes Zoster Virus (HZV) Infections Among Multiple Sclerosis Patients Treated with Various Disease-Modifying Therapies. International Journal of MS Care. 2020 May 2;22.
7. Longbrake E, Obeidat A, Dunn J, Sicotte N, Hua L. Defining the Neuroimmunology/Multiple Sclerosis Subspecialty: Surveys of Fellowship Training in the United States (699).
8. Aladawi M, Salter A, Maynard M, Obeidat A. Ma2 paraneoplastic limbic encephalitis: Examination of potential prognostic factors and effects of various immunotherapeutic approaches (4894).
9. Hooshmand S, Carlisle N, Maynard M, Hoffman L, Obeidat A. Analysis of Reported Deaths While Exposed to Disease-Modifying Therapies for Multiple Sclerosis (2855).
10. Block AN, Maynard M, Obeidat AZ. Novel Clinical Observations in Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disorders. In2019 Annual Meeting of the Consortium of Multiple Sclerosis Centers 2019 May 30. CMSC.
11. Obeidat A, Annadurai V, Zabeti A, Goldstick L. The Middle Cerebellar Peduncle Lesion in Natalizumab-Treated Multiple Sclerosis Patients: Think Twice Before Assuming a Relapse (P5. 349).
12. Obeidat AZ, Bowman M, Dragan E, Goldstick L, Zabeti A. Low Dose Naltrexone in Multiple Sclerosis: Web-Presence Versus Scientific Evidence. InMULTIPLE SCLEROSIS JOURNAL 2018 Feb 1 (Vol. 24, pp. 76-76). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD.
13. Annadurai V, Zabeti A, Illingworth AA, Obeidat AZ. Rapid Evolution of Natalizumab-Associated Brainstem PML–IRIS: Lessons Learned in Diagnosis and Management. InMultiple Sclerosis Journal 2018 Feb 1 (Vol. 24, pp. 46-47). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD.
14. Obeidat AZ, Subbiah B, Tomsick T, Khatri P. Developmental Venous Anomalies in Neurological Disease: A Report of Six Cases (P4. 059).
15. Obeidat AZ, Subbiah B, Zabeti A. On the History of Multiple Sclerosis and War (P2. 044).
16. Van Sanford C, Obeidat A, Zabeti A. Ring Enhancing Brain Lesions in a Patient With Sarcoidosis: A Diagnostic Challenge.(P1. 306).
17. Obeidat AZ, Dragan E, Zabeti A. The 10-Point Disability Scale in Multiple Sclerosis: Phase I Development and Planning study (P2. 062).
18. Obeidat AZ, Ramirez R, Halper J. The Status of Multiple Sclerosis and Neuroimmunology Fellowship Training in the United States: A Pilot Study. InACTRIMS Forum 2017 2017 Feb 23. ACTRIMS.
19. Obeidat AZ, Jacob CA, Zabeti A. Neuromyelitis optica was the answer! Not lupus or sjogren. InACTRIMS Forum 2016 2016 Feb 19. ACTRIMS.
20. Obeidat AZ, Sucharew H, Moomaw CJ, Kleindorfer DO, Kissela BM, Alwell K, Flaherty M, Broderick JP, Woo D. Abstract WP190: Clinical Features of Sarcoid Patients With Ischemic Stroke. Stroke. 2016 Feb;47(suppl_1):AWP190-.
21. Obeidat AZ, Sucharew H, Moomaw CJ, Kleindorfer DO, Kissela BM, Alwell K, Flaherty M, Broderick JP, Woo D. Abstract WP190: Clinical Features of Sarcoid Patients With Ischemic Stroke. Stroke. 2016 Feb;47(suppl_1):AWP190-.
22. Obeidat A, Zabeti A. A Case of Duane Syndrome, Developmental Venous Anomalies, Hydrocephalus, and Multiple Sclerosis: Possible Link or Just a Co-Incidence?(P4. 075).
23. Obeidat A. Localization of fluorescent probes in rat brain tissue stained with hematoxylin: a methodology development study. Celebration of Research, Scholarship, and Creative Activities. 2010.
24. Obeidat AZ, Cope TC. The Recurrent Debate on Renshaw Inhibition and Spinal Motoneuron Firing Behavior. Gordon Research Conferences: Inhibition in the CNS. Accepted for poster presentation. Lewiston, ME, 8/2015.
25. Obeidat AZ, Cope TC. The Musical Notes of Motoneuron Firing. Society for Music, Perception and Cognition Meeting. Accepted for poster presentation, Nashville, TN, 8/2015.
26. Obeidat AZ, Zabeti A. Delayed Tumefactive Demyelination in a Patient with Meningioma and Optic Neuritis: Case Report and Review of the Literature. The Consortium of Multiple Sclerosis Centers Annual Meeting. Accepted for poster presentation. Indianapolis, IN, 5/2015.
27. Obeidat AZ, Zabeti A. Appearance of Balo’s Concentric Sclerosis Eighteen Years after Acute Psychosis. The Consortium of Multiple Sclerosis Centers annual meeting. Accepted for poster presentation. Indianapolis, IN, 5/2015.
28. Obeidat AZ, Cope TC, Diminished Participation of Regenerated Motoneurons in Recurrent Inhibitory Circuits. Cellular and Network Functions in the Spinal Cord Symposium. Madison, WI, 5/2012.
29. Obeidat AZ, Nardelli P, Powers RK, and Cope TC. Recurrent Inhibition and Motoneuron Firing Behavior: Rate, Timing, Adaptation. Program No. 745.09. 2013 Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. San Diego, CA
30. Obeidat AZ, Cope TC. Stressful Life Events and Multiple Sclerosis: A Call for Re-Evaluation. The Consortium of Multiple Sclerosis Centers Annual Meeting. Orlando, FL, 5/2013.
31. Obeidat AZ, Nardelli P, Powers RK, Cope TC. Recurrent Inhibition and Motoneuron Firing Behavior: Rate, Timing, Adaptation. Ohio Miami Valley Neuroscience Day Symposium. Cincinnati, Ohio, 6/2013.
32. Obeidat AZ, Cope TC. Firing Rate Modulation by Recurrent Inhibition in Adult Rat Motoneurons. Program No. 789.09. 2012 Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. New Orleans, LA, 10/2012.
33. Obeidat AZ, Rotterman TM, Alvarez FJ, Cope TC. Global Changes in Recurrent Inhibition Following Peripheral Nerve Repair. Program No. 789.12. 2012 Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. New Orleans, LA, 10/2012.
34. Obeidat AZ, Cope TC, Modulation of Afterhyperpolarization by Recurrent Inhibition. Cellular and Network Functions in the Spinal Cord Symposium. Madison, WI, 5/2012.
35. Obeidat AZ, Rotterman T M, Nardelli P, Alvarez FJ, Cope TC, Regeneration Fails to Restore Spinal Circuits, Ohio Miami Valley Neuroscience Day Symposium. Oxford, Ohio, 5/2012.
36. Obeidat AZ, Rotterman T M, Nardelli P, Alvarez FJ, Cope TC, Permanent Alterations in Recurrent Inhibition after Peripheral Nerve Injury. Program No. 74.24. 2011 Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. Washington, DC 11/2011.
37. Spokane RB, Kent MN, Nagy JO, Obeidat AZ, Leasure JE, Johnson JM, Olson JE, Novel Nanoparticles for Delivering Magnetic Resonance Contrast Agents Across the Blood-Brain Barrier. Program No.714.5. 2010. Neuroscience Meeting Planner. Society for Neuroscience Annual Meeting. San Diego, CA, 11/2010.
38. Obeidat AZ, Variations of Neural Tube Defects in Jordan. The17th Conference of the Union of Arab Pediatricians and the Fifth Meeting of the Pan Arab Neonatology Forum. Amman, Jordan, 5/2009